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Orofacial Manifestations of Lyme Disease: A systematic review
Brenda T. Bradshaw, RDH, MSDH; Kelsey M. Jones, BS;
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Abstract:
Purpose: Orofacial manifestations of Lyme disease can affect head and neck anatomical structures that are frequently
examined by dental professionals. The purpose of this systematic review was to examine the literature for types and frequencies
of orofacial manifestations documented in populations in the United States (US) with Lyme disease.
Methods: Four electronic databases (Dentistry and Oral Sciences, PubMed, Cinahl Plus, and Medline) were systematically
searched during the summer of 2019 using keywords and MeSH terms to identify relevant studies. Search term alterations and
synonyms were cross-checked using the US National Library of Medicine Unified Medical Language System Metathesaurus.
Full-text, English language studies were included if they reported on US populations with Centers for Disease Control
and Prevention confirmed cases of Lyme disease. The review followed guidelines set forth in Preferred Reporting Items for
Systematic Reviews and Meta-Analysis (PRISMA). Quality was assessed with a modified version of the Cochrane Data
Collection Form for Randomized Control Trials and Non-randomized Control Trials. Extracted data was organized by
themes of manifestations and the frequencies were calculated.
Results: An initial search extracted 217,381 articles; 43 met the inclusion criteria and were further reviewed for quality.
Twelve articles published from 1992-2017 were deemed appropriate for inclusion. All were from non-dental journals and
fewer than half (n=6) reported on Lyme disease endemic states. Eight incidences of orofacial manifestations within head/
neck regions were documented in Lyme disease patients (n=951) and included: headache (39.5%), facial palsy (42.5%),
temporomandibular joint arthralgia (42.0%), altered taste (11.0%), stiff neck (13.6%), sore throat (3.0%), neck pain/arthralgia
(7.5%), and erythema migrans rash (5.2%).
Conclusion: Eight orofacial manifestations of Lyme disease were revealed by this systematic review. Future research
regarding the orofacial manifestations of Lyme disease is needed so this medical condition can be better understood by oral
health care providers and result in improved health outcomes for infected patients.
Key words: Lyme disease, orofacial manifestations, oral care, dental hygienists, oral health care providers, systematic review
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Introduction
Lyme disease, the most common vector-borne disease in
the United States (US), is transmitted by ticks infected with
Borrelia burgdorferi sensu stricto (Bbss) or Borrelia mayonii.1
Carriers of the pathogen include Ixodes scapularis (commonly
known as the deer tick or blacklegged tick), and Ixodes pacificus
(commonly known as the western blacklegged tick).2 The Bbss
spirochetal bacterium is transferred to human hosts during
the blood meal of an infected tick, with the incubation period
in humans, prior to symptom onset, ranging from three to
thirty days.3,4 First recognized in Connecticut in the 1970s,
Lyme disease was added to the National Notifiable Disease
The Journal of Dental Hygiene

Surveillance System in 1991.1,5 Since then, the number of
reported cases and geographical distribution of the disease
has quickly spread across the country and is now considered
endemic in 14 states including Connecticut, Delaware, Maine,
Maryland, Massachusetts, Minnesota, New Hampshire, New
Jersey, New York, Pennsylvania, Rhode Island, Vermont,
Virginia, and Wisconsin.1,5 States that share a border or
are located between high endemic states, are classified as
“neighboring states” and are also showing an increased
incidence of confirmed cases.5 Over 275,000 cases of Lyme
disease were reported to the Centers for Disease Control
23

Vol. 95 • No. 4 • August 2021

(CDC) from 2008-2015.5 Currently, state health departments
report 30,000 new cases of Lyme disease to the CDC each
year;2 however, the number of reported cases is estimated to be
much lower than the number of diagnosed cases – potentially
by ten-fold.1,6 The increasing incidence of this infectious disease
is of growing concern, and as members of interdisciplinary
health care teams oral health care professionals need to be
aware of the signs and symptoms.
Lyme disease affects multiple body organs, and if left
untreated can potentially be life threatening; obtaining an early
diagnosis through interprofessional care is critical. The CDC
is asking all health care providers to educate themselves about
the full range of the presenting signs and symptoms of Lyme
disease to minimize the morbidity of the disease.3,4 When
diagnosed and treated early, patients can be successfully cured
and report fewer residual complications.5 However, obtaining
an early diagnosis for this complex disease is difficult in many
cases due to the limitations of serological tests coupled with the
onset of signs and symptoms that can vary significantly from
person-to-person and also mimic a multitude of other ailments
depending on the dissemination stage.3,4,6
The localized early stage may appear within 3-30 days after
an infected tick bite and typically begins with an expanding
skin lesion, erythema migrans, commonly known as the bull’s
eye rash.4 Erythema migrans is considered to be a critical sign
of Lyme disease and is often used to make a clinical diagnosis.
However, the rash only appears in 70-80% of cases and may
be missed if it presents on the back half of the body, on darker
skin tones, or has an atypical appearance.4 Early stages may
also include fever, chills, headache, fatigue, muscle and joint
aches, and lymphedema.4 During the disseminated stage,
seven days to several months after the initial infection, signs
and symptoms may include severe headaches, neck stiffness,
additional erythema migrans lesions, arthritis, and facial
palsy.4 Individuals may also experience nerve pain, problems
with short-term memory, irregular heartbeat, inflammation
of the brain and spinal cord, shooting pains, numbness, and/
or tingling in the hands or feet.4 The signs and symptoms
may appear atypical or not at all, further complicating the
ability to obtain a timely diagnosis. Orofacial manifestations
of Lyme disease have appeared in the health care literature,
but they have not been a research focus despite reports
indicating that orofacial manifestations may be the first signs
and symptoms to appear.7 The possibility of Lyme disease
should be a consideration for oral health care professionals
when patients present with unexplained facial paralysis,8-17
neck stiffness,11,13,15,18 headache,8-13,15-19 TMJ pain,10,13 altered
taste,19 sore throat,12 and neck pain,10,12,13,17,19 when a clinical
examination fails to identify a specific oral health pathology.
The Journal of Dental Hygiene

The orofacial manifestations of Lyme disease affect head
and neck anatomical areas that are routinely examined by
oral health care professionals. A 2014 study found that 46%
of surveyed health care providers had encountered a Lyme
disease patient, and the researchers concluded that health
care providers in general required more education about
Lyme disease in order to promote an early diagnosis.20 This
also points to the possibility that many dental professionals
may be unaware of the orofacial manifestations linked to
Lyme disease. This missed opportunity for making a timely
diagnosis may allow the disease to progress to later stages
characterized by chronic suffering and life-threatening
conditions that are difficult to treat, negatively affecting
the patient’s quality of life. Furthermore, patients often
experience frustration when seeking a diagnosis due to health
care professionals who may be disrespectful and dismissive
because of not being well educated in the signs and symptoms
of Lyme disease.21 It is important for dental professionals to
be aware of the orofacial manifestations of Lyme disease
and to have a referral and follow-up plan with primary care
physicians to achieve the best possible health outcomes for
their patients. The purpose of this systematic review was to
examine the literature to identify the frequencies of orofacial
manifestations documented in Lyme disease patients in the
US to help inform oral health care providers of the orofacial
manifestations of the disease.

Methods
This systematic review followed the guidelines set forth in
PRISMA (Preferred Reporting Items for Systematic Reviews
and Meta-Analyses).22 An electronic search of the literature
was conducted by a university health and life sciences librarian
from May 2019 until October 2019 and included the following
databases: Dentistry and Oral Sciences Source (EBSCO),
PubMed (first search), Cinahl Plus with Full Text (EBSCO),
and Medline (first search) for articles published from January
1990 to October 2019. Several search term alterations were
used and synonyms for the key search terms were crosschecked using the United States National Library of Medicine
Unified Medical Language System Metathesaurus®.23 The
search strategy used keywords and MeSH terms that included
terminology and synonyms for Lyme disease, vector, pathogen,
head/neck anatomical landmarks, and orofacial manifestations.
The search was limited to peer-reviewed journals, articles which
included populations of Lyme disease patients diagnosed in
accordance with CDC protocol in the US, and full-text articles
in the English language. Articles were included if they met the
following criteria: 1) Studies that include populations from the
US, 2) available in full-text and in the English language, and 3)
confirmed CDC diagnosis of Lyme disease. Exclusion criteria
24
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included: 1) studies of non-US populations, 2) studies involving
animal subjects, 3) tick-borne diseases other than Lyme disease,
and 4) studies that did not confirm a Lyme disease diagnosis.
A citation managing system (EndNote X9; Clarivate
Analytics, Philadelphia, PA) was utilized to organize identified
articles. There were no limits on study designs, but grey
literature and letters to editors were excluded. Retrieved articles
were independently reviewed for appropriateness based on titles
and abstracts by two researchers (BB and KJ). Meetings for
discussion were held to resolve disagreements that were settled
by consensus. Risk of bias was assessed independently by BB and
KJ, and data extraction was completed using a modified version
of the Cochrane Data Collection Form for Randomized Control
Trials and Non-randomized Control Trials and meetings were
held to resolve disagreements by consensus.

Results
An initial search of the databases produced a total of
217,381 results after filters and limits based on inclusion/
exclusion criteria were applied. The titles and abstracts were
further filtered based on exclusionary criteria, resulting in
744 articles to be reviewed. Ninety-five were removed due to
duplication, yielding 649 articles. Two reviewers (BB and KJ)
independently screened each of the 649 articles by titles and
abstracts to identify additional articles that should be excluded
due to a lack of relevancy; disagreements were settled by
consensus, resulting in the removal of 441 articles. Exclusions
based on titles and abstracts were made for the following
reasons: published before 1990, orofacial manifestations were
not addressed, articles were not accessible, letters to editors,
not peer-reviewed, full text not available, only available as
a research poster, and non-human research. The remaining
full-text articles (n=208) were further independently reviewed
based on inclusion/exclusion criteria and risk of bias, resulting
in the removal of 196 articles after disagreements were settled
by consensus. Articles were rated as poor, fair, or good based
on the risk of bias tool (Table I). Articles removed due to risk
of bias (n=31) included case studies, and literature reviews
that did not report data collected from human subjects. Items
determined to be “fair” or “poor” were included if relevant
data was reported. Articles removed for not meeting the
inclusion criteria (n=165) included those that were foreign,
did not follow CDC serological protocol, and articles that did
not report results of Lyme disease from patients with orofacial
manifestations. Clinical trials meeting inclusion/exclusion
criteria were not identifiable.
A total of twelve articles were judged as being acceptable
for inclusion in the systematic review for synthesis. Seven
(58%) of the included studies were from the 1990s,10-13,16,17,19
The Journal of Dental Hygiene

Table I. Risk of bias ratings for 12 included articles
Article (year):
Avery (2006)

Cohn (2012)

Risk of bias rating:
Fair

8

Good

9

Dattwyler (1997)

Good

12

Gerber (1996)

Good

18

Liveris (2002)

Good

Nadelman (1996)13

Good

11

Payder-Darian (2017)14

Fair

Peltomaa (2004)

Poor

Smouha (1997)

Fair

Belman (1992)

Poor

Cook (1997)

Poor

Jain (1996)

Fair

15

16

17

10

19

three (25%) from the 2000s,8,15,18 and two (17%) were from the
2010s.9,14 Publication sources for the twelve articles included
several journals: The Journal of Clinical Microbiology (2),18,19
The New England Journal of Medicine (2),11,12 Pediatrics (2),8,9
The American Journal of Otology (1),16 Otology & Neurotology
(1),15 The Journal of Pediatric Infectious Diseases Society (1),14
The American Journal of Medicine (1),13 Neurology (1),17 and
The American Journal of Otolaryngology (1).10 The PRISMA
flow chart of the results of included and excluded studies is
shown in Figure 1.
Data extraction of the included articles was completed
independently by BB and KJ to include the first author,
year, demographic information of the study populations,
confirmation of Lyme disease, and presence of orofacial
manifestations. Articles included for synthesis documented
orofacial manifestations of Lyme disease in human patient
populations in the endemic states of Delaware (25%, n=3),8-10
Massachusetts (33%, n=4),9,11,14,15 Pennsylvania (17%, n=2),9,10
New Jersey (8%, n=1),10 Connecticut (25%, n=3),12,15,19 and
New York (42%, n=5).13,16-19 Demographic characteristics
of the patient populations varied in the twelve studies. All
articles included both males and females, however nine
included mostly males (75%, n=9),8-13,15-17 only two articles
were predominately of female populations (17%, n=2),18,19
and one article did not make a clear distinction.14 The age
ranges of the studied populations also varied. Six articles
included a mixture of ages from childhood to adulthood
(50%, n=6),10-13,15,16,19 four included children and adolescents
(33%, n=4),8,9,14,17 and one focused only on adults (8%, n=1).18
Six of the studies were retrospective (50%, n=6),8-10,14-16 five
were prospective (42%, n=5),11-13,18,19 and one followed an
25
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Figure 1. PRISMA Flowchart of article retrieval and
study selection
Dentistry and Oral Sciences Source
(EBSCO)= 18
PubMed= 719
Cinahl= 257
Medline= 216,387
Total= 217,381

Articles to be reviewed
n= 744

Exclusions made with filters
and limitations
n= 216,637

Duplicates excluded
n= 95

Articles after
duplicates removed
n= 649

Articles screened by
titles and abstracts
n= 649

Articles excluded
n= 441

Full text articles reviewed
n=208

Articles excluded based on
inclusion/exclusion criteria
n=165

Articles reviewed for quality
n=43

Articles excluded based
on risk of bias
n=31

Articles included in
systematic review
n=12

observational design (8%, n=1).17 In half of the articles (50%,
n=6), the number of times orofacial manifestations appeared
was more than that of the number of total patients;10,11,15-17,19
in one article they appeared the same number of times (8%,
n=1),14 and in five articles they appeared only slightly less
(42%, n=5).8,9,12,13,18 Patient demographics and the frequency
of orofacial manifestations by article are shown in Table II.
Eight orofacial manifestations were reported among
the included articles: headache,8-13,15-19 facial palsy,8-17,19
temporomandibular joint arthralgia,10,13 altered taste,19 stiff
neck,11,13,15,18 sore throat,12 neck pain/arthralgia,10,12,13,17 and
erythema migrans rash on the head or neck.12 The frequencies
of orofacial manifestations per study are shown in Figure 2.
Among the twelve included articles, there were a total of 951
confirmed cases of Lyme disease. The frequencies of the eight
orofacial manifestations among those confirmed cases were
reported as follows: headache (39.5%, n=376),8-13,15-19 facial
palsy (42.5%, n=404),8-17,19 temporomandibular joint arthralgia
(.42%, n=4),10,13 altered taste (.11%, n=1),19 stiff neck (13.6%,
n=129),11,13,15,18 sore throat (3.0%, n=29),12 neck pain (7.5%,
The Journal of Dental Hygiene

n=71),12,13,17,19 and erythema migrans rash on the head or neck
(5.2%, n=49).12 The frequencies of orofacial manifestations
per study are shown in Table III.

Discussion:
The scientific literature was systematically reviewed to
synthesize information regarding the orofacial manifestations
of Lyme disease that would be most relevant to oral health
care providers. Studies that met the inclusion criteria from
1992-2017 were published in journals that do not target the
dental professional audience. There is a need for this timely
research to appear in dental and dental hygiene journals so
that the oral health care community is informed regarding
the various ways this growing infectious disease may be
manifested within their patient populations. Additionally,
none of the included research studies discussed clinical
assessments or scales that could be used to quantify the
severity of Lyme disease related orofacial manifestations.
Such diagnostic tools along with recommendations on how to
best manage the orofacial manifestations to ease discomfort,
improve function, and track recovery or relapse would be
beneficial to oral health care professionals.
Fewer than one half (n=6) of the US endemic states
(n=14) were represented in the included studies. More
studies are needed in the literature from other endemic and
neighboring states, especially since the CDC Morbidity and
Mortality Weekly Report concluded that incidence rates are
increasing in neighboring states.5 Oral health care providers
who practice in those geographic areas need to have evidencebased information regarding how to care for affected patient
populations. The literature also does not report orofacial
manifestations evenly across demographics. Since disease
transmission does not discriminate between genders, studies
are needed to fully represent both males and females. An
underrepresentation of females in the literature may be of
concern especially for those residing in low incidence states,
since Lyme disease has been found to be more common
among females in states with low incidence rates.5
A total of eight orofacial manifestations were documented
in the included studies. Half of the studies reported higher
frequencies of these manifestations than the total number of
study participants likely due to participants who experienced
multiple oral manifestations. Regarding patients who present
with orofacial symptoms of unknown origin, oral health
care providers should carefully document their findings
following a thorough health history interview and extra/
intraoral examination. Questions that may assist dental
hygienists and dentists while conducting a health history
interview when Lyme disease infection is suspected could
26
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Table II. Number of patients with Lyme disease per article compared with frequencies
of orofacial manifestations in the sample populations

Author
(Year)

Age Range
(years)

Male

Female

Confirmed
Lyme disease
patients

Frequencies
of orofacial
manifestations

n(%)

n(%)

n

n

Age Mean
(years)

Reported as Lyme disease only; excludes orofacial manifestations
Avery (2006)8

2.7 - 13.1

9.4

18 (67.0)*

9 (33.0)*

27*

25

Cohn (2012)9

7.2 - 13.1**

-

81 (69.0)*

36 (31.0)*

117*

113

Dattwyler (1997)11

7 - 85

42.6

87 (62.0)*

53 (38.0)*

140*

147

Gerber (1996)12

1 - 21

7.8

131 (65.0)*

70 (35.0)*

201*

187

Liveris (2002)18

21 - 72

46.6

23 (46.0)*

27 (54.0)*

50*

44

Nadelman (1996)13

16 - 76

43

49 (62.0)*

30 (38.0)*

79*

71

Reported as Lyme disease and orofacial manifestations combined
Payder-Darian (2017)14

7.2 - 13.1**

9.8

unclear

unclear

204

204

Peltomaa (2004)15

4 - 74

-

25 (53.0)

22 (47.0)

47

104

Smouha (1997)16

5 - 69

32

30 (60.0)

20 (40.0)

50

55

Belman (1992)17

4 - 14

8.2

5 (71.4)

2 (28.5)

8*

9

Cook (1997)10

3 - 18

10

18 (72.0)

7 (28.0)

25

49

Jain (1996)19

6 - 60

26.3

1 (33.0)

2 (67.0)

3

6

*Number includes those with Lyme disease, does not exclude on the basis of whether or not an OM was present.
**IQR=reported as interquartile range

include: “Have you noticed a red, circular skin rash?”, “Have
you worked or played outdoors within the last month?”, “Do
you recall a recent insect bite?”, “Have you recently traveled
to states known to be endemic for Lyme disease?”, and “Have
you been tested by your medical physician for Lyme disease?”.4
Occurrences of these orofacial manifestations should be taken
into consideration for any type of differential diagnoses when
the typical oral pathologies of trauma or infections cannot be
identified. This is particularly important since these presenting
signs and symptoms can occur during the localized early stage
of Lyme disease when serology testing may fail.
The Journal of Dental Hygiene

Eight of the included studies reported headache, neck pain/
arthralgia, sore throat, facial paralysis, stiff neck, altered taste,
and TMJ arthralgia as orofacial manifestations appearing
during the early stage of disease,11-15,17-19 and two studies reported
headache, neck pain, and sore throat during the late stage of
disease.12,17 Four included studies did not specify early or late
dissemination for disease stage of the sample populations.8-10,16
While the majority of reported orofacial manifestations appeared
during early dissemination among these studies, it is difficult
to say this is enough evidence to generalize that all orofacial
manifestations primarily occur during early dissemination of
27
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the disease. Future research should include
specific details about the timeframe of when
signs and symptoms appear in the disease
process so that a pattern of correlation may
be identified over time. Oral health care
providers with a keen awareness of the role of
these oral manifestations could refer a patient
for medical examination when Lyme disease
is suspected, increasing the chances of making
a timely diagnosis.

Figure 2. Frequencies of orofacial manifestations
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A total of 951 patients were confirmed to
have Lyme disease across the twelve studies.
Headache and facial palsy were reported most
frequently while temporomandibular joint
arthralgia and altered taste were reported
the least. Low frequencies of neck stiffness
and temporomandibular joint arthralgia

Table III a. Reported orofacial manifestations in confirmed cases of Lyme disease per article
Manifestation:
Headache

Facial palsy

Avery8

Cohn9

Cook10

Dattwyler11

Gerber12

n=16 (59%);
>3 days duration

n=56 (52.0%)

n=14 (56.0%)

n=43 mild
n=27 moderate
n=25 severe

n=55 (23%) early stage
n=39 (19%) early stage
n=4 (2%) late stage

n=10 (7%)

n=6 (3%) early stage

n=9 (33.0%);
1 was bilateral

TMJ arthralgia

n=57 (70.0%)

n=4 (56.0%) right side;
n=11 (44.0%) left side;
Duration was 2-20 weeks;
average was 5.24 weeks
n=2 (8.0%)

Altered taste
n=28 mild
n=19 moderate
n=5 severe

Stiff neck

n=16 (8.0%) early stage
n=11 (5.0%) early stage
n=2 (1%) late stage

Sore throat
Neck pain/
arthralgia

n=8 (32.0%)

Of the 188 patients with
a single EM rash, 26.0%
(n=49) had it on the head
or neck

Head/neck
erythema migrans
(EM) rash

The Journal of Dental Hygiene

n=34 (17.0%) early stage
n=19 (9.0%) early stage
n=1 (.5%) late stage

EM rash on head/neck
occurred significantly more
in younger patients (mean
age of 5.9, p<0.01)
28
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Table III b. Reported orofacial manifestations in confirmed cases of Lyme disease per article
Manifestation:

Jain19

Liveris18

Nadelman13

Headache

n=1

n=19
(38.0%)

n=33
(42.0%)

Facial palsy

n=3;
2 were unilateral;
1 was bilateral

n=1 (1.0%)

TMJ arthralgia
Altered taste

Paydar-Darian14

n=204 (100%)

Peltomaa15

Smouha16

Belman17

n=33 (70.0%)

n=5 (10.0%)

n=6 (75.0%)

n=41 (87.0%) n=46 (92.0%)
unilateral;
unilateral;

n=1 (12.5%)
unilateral;

n=6 (13.0%)
bilateral

n=1 (12.5%)
bilateral

n=4 (8.0%)
bilateral

n=2 (2%)
n=1
n=25
(50.0%)

Stiff neck

n=28
(35.0%)

n=24 (51.0%)

Sore throat
Neck pain/
arthralgia

n=1

n=7 (9.0%)

n=1 (12.5%)

Head/neck
EM rash

was a surprising finding since the review process revealed
several articles and case studies which reported those two
symptoms as primary orofacial manifestations.7,24-34 However,
case studies were excluded from this systematic review, due to
the high for risk of bias. Considering that neck stiffness and
temporomandibular joint arthralgia appeared in several case
studies and have been recognized by the CDC as Lyme disease
symptoms,2 they may merit further study.
Avery et al, devised a statistical model to help predict Lyme
meningitis and stated that odds ratios for headaches can serve
as an independent predictor of the condition and found that
headache duration was an independent predictor of Lyme
meningitis in children in an endemic region.8 This model
allowed practitioners to calculate the probability from .01 to
.99 of children having Lyme meningitis.8 Each additional day
of headache duration increased the odds ratio of having Lyme
disease by 0.136.8 The Avery prediction model was compared
against a “rule of 7’s” prediction model devised by Cohn et al.
This prediction model classifies suspicious cases as “low risk”
when 3 of the following criteria are met: “<7 days of headache,
<70% cerebrospinal fluid mononuclear cells, and absence of
seventh or other cranial nerve palsy.”9 Cohn et al reported
that both the Avery model and the rule of 7’s performed well
when applied to a sample population of children. However,
the rule of 7’s model had higher sensitivity (96% [95% CI:
90%-99%]) compared to the Avery model (83% [95% CI:
75%-89%]); and fewer misclassifications when assessing
patient risk for Lyme disease.9
The Journal of Dental Hygiene

Smouha et al applied a researcher-designed clinical
probability scale compared against serology test results to
determine if clinical signs and symptoms could accurately
assess Lyme disease probability.16 The researchers defined
clinical probabilities of Lyme disease signs and symptoms
including orofacial manifestations: “definite” probability
(erythema migrans rash), “high” probability (headache and stiff
neck), “intermediate” probability (arthralgias), and “possible”
(headache alone).16 However, they concluded that the majority
of disease predictors could not be made solely based on clinical
data, which contrasts findings from Avery’s prediction model
and Cohen’s rule of 7’s model.16 Risks or odds ratios for orofacial
manifestations should be investigated by validated prediction
models to determine whether they can assist health care providers
who encounter suspicious cases. Since patients presenting with
orofacial manifestations are considered medical emergencies,
the ability for oral health care providers to apply risk prediction
models until serology test results are available, and may help
reduce unnecessary antibiotic prescriptions, invasive medical
procedures and support timely referrals.
Generalizability of this systematic review is limited
because studies of populations outside of the US were not
included as Lyme disease variants in other countries may
differ from those found in the US. Additionally, the Cochrane
Data Collection Form for Randomized Control Trials and
Non-randomized Control Trials was modified as there were
few randomized control trials identified in the literature that
met the inclusion criteria.
29
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Future research focused on the eight orofacial manifestations associated with Lyme disease as presented in
oral health care settings is needed. Additionally, there
were other less common orofacial manifestations of Lyme
disease reported as case studies that were not included in
this review. A systematic review of case studies could be
helpful to investigate the phenomenon of these less common
manifestations. Case-control studies of integrated electronic
medical and dental records could be conducted to investigate
the frequencies of orofacial manifestations of confirmed Lyme
disease cases against healthy cases from endemic states to
support evidence-based decision making for all health care
providers. Future studies should also investigate the efficacy
of integrated electronic medical and dental records to improve
the interprofessional collaboration of health care professionals
for the management of patients with Lyme disease.
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Conclusion
This systematic review researched orofacial manifestations
of Lyme disease that could be recognized by oral health care
providers. Eight orofacial manifestations of Lyme disease
have been well documented in the literature. Ongoing
research regarding the orofacial manifestations of Lyme
disease is needed so that this medical phenomenon can be
well understood by dental professionals in order to best serve
their patients.
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